BioCentury
ARTICLE | Clinical News

Abstral fentanyl regulatory update

March 1, 2010 8:00 AM UTC

Kyowa Hakko submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for Abstral fentanyl (KW-2246) to treat breakthrough cancer pain in patients already receiving opioid treatment. Th...